Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Alain Masson | Deputy CEO & Pharmacist Manager | 196.16k | -- | 1962 |
Mr. Matthieu Frechin | CEO & Non-Independent Chairman of the Board | 490.68k | -- | 1969 |
Mr. Regis Vimal du Monteil | Chief Financial Officer | -- | -- | 1965 |
Mr. Dominique Derveaux | Chief Operations Officer | 382.12k | -- | 1969 |
Philippe Gruet | Chief Scientific Officer | -- | -- | -- |
Sandrine Perrier | Chief Information Officer | -- | -- | -- |
Laurent Thore | Director of Partnerships, Legal Affairs & Risks | -- | -- | -- |
Xavier Berthet | Director of Group Communications | -- | -- | -- |
Ms. Isabelle Proust-Cabrera | Group Director of Human Resources | -- | -- | -- |
Vetoquinol SA
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Corporate Governance
Upcoming Events
March 20, 2025 at 3:00 PM UTC
Vetoquinol SA Earnings Date
Recent Events
June 4, 2024 at 12:00 AM UTC
Ex-Dividend Date